VA TAVR Results Comparable to Outside Care

How do veterans fare when they undergo transcatheter aortic valve replacement with the VA? That was the question asked by a study which sought to examine their association with short- and long-term mortality, length of stay, and rehospitalization within 30 days.

Cardiologist Visits Increase Statin Use at VA

HOUSTON—Statin use remains suboptimal in patients with atherosclerotic cardiovascular disease, according to a VA study trying to find out why. Michael E. DeBakey VAMC researchers and colleagues assessed whether outpatient care with a cardiology provider is associated...

No Link Between Anthrax Vaccine, ‘Lone AFib’

ATLANTA—Concerns have been raised about a possible link between receipt of anthrax vaccine adsorbed and atrial fibrillation in military personnel without identifiable underlying risk factors or structural heart disease. A study in Human Vaccines & Immunotherapies...

Improving OAC Adherence in Atrial Fibrillation Patients

DURHAM, NC—Treatment of atrial fibrillation patients isn’t always in line with clinical guidelines, but improving adherence to oral anticoagulation has proven to be challenging, according to a new study. The article in Circulation reported on adherence to the American...

Using EMR to Improve Statin Adherence in MHS

DURHAM, NC -- Even though HMG-CoA reductase inhibitors (statins) lower cholesterol and prevent cardiovascular disease, nearly half of patients stop taking statin medications one year after they are prescribed. A study published by PLoS One noted that discontinuation...

Aspirin Appears to Be Safe for Some Heart Failure Patients

SAN FRANCISCO – Does use of aspirin increase heart failure (HF) hospitalization or risk of death in patients with reduced ejection fraction receiving an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB)? That was the question...

Aspirin Appears to Be Safe for Some Heart Failure Patients

SAN FRANCISCO – Does use of aspirin increase heart failure (HF) hospitalization or risk of death in patients with reduced ejection fraction receiving an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB)? That was the question...

U.S. Medicine Archives

U.S. Medicine Supplements

CE Credits